Envestnet Asset Management’s AbCellera Biologics ABCL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.8K | Sell |
18,310
-3,650
| -17% | -$12.5K | ﹤0.01% | 4380 |
|
|
2025
Q1 | $49K | Buy |
21,960
+3,532
| +19% | +$7.88K | ﹤0.01% | 4295 |
|
|
2024
Q4 | $54K | Sell |
18,428
-4,781
| -21% | -$14K | ﹤0.01% | 4260 |
|
|
2024
Q3 | $60.3K | Buy |
23,209
+8,210
| +55% | +$21.3K | ﹤0.01% | 4169 |
|
|
2024
Q2 | $44.4K | Buy |
14,999
+814
| +6% | +$2.41K | ﹤0.01% | 4113 |
|
|
2024
Q1 | $64.3K | Buy |
14,185
+1,021
| +8% | +$4.63K | ﹤0.01% | 4093 |
|
|
2023
Q4 | $75.2K | Buy |
13,164
+1,364
| +12% | +$7.79K | ﹤0.01% | 3965 |
|
|
2023
Q3 | $54.3K | Buy |
+11,800
| New | +$54.3K | ﹤0.01% | 3933 |
|